Clin2
NCT07022912Possibly a fitNot yet recruiting

Studying GERD in scleroderma that doesn't respond to PPI

Systemic Sclerosis (SSc)GERD (Gastroesophageal Reflux Disease)

Part of Digestive system, Skin clinical trials.

This study looks at why people with systemic sclerosis (scleroderma) still have bad heartburn or regurgitation even when they take strong acid-reducing medications. It aims to find better ways to understand and manage these symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
147 people
Ages
16 years and older
Study type
Observational

Who can take part

  • You have a confirmed diagnosis of systemic sclerosis (scleroderma).
  • You still experience heartburn or regurgitation at least 3 times a week, even while taking acid-reducing medication (PPI).
  • You have not had surgery on your esophagus, stomach, or upper digestive tract.
  • You do not have severe heart or lung disease that requires IV treatments or oxygen therapy.
  • You are not pregnant or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07004400Not yet recruiting
New surgery vs. standard surgery for GERD

This trial compares a new device called RefluxStop to a standard surgery (Nissen fundoplication) for treating long-term acid reflux. It aims to see which one works better at stopping heartburn and other symptoms.

Vienna
NCT07624383Recruiting
New topical treatment for nonerosive acid reflux disease

This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.

Warsaw, Masovian Voivodeship
NCT07402226Recruiting
Diet study for bloating with scleroderma

This study tests whether a special diet can help reduce bloating and stomach discomfort in people with scleroderma (systemic sclerosis). You'll follow a specific meal plan to see if it improves your digestive symptoms.

Ann Arbor, Michigan
NCT05696184Recruiting
Studying why reflux reaches the throat and what stops it

This study looks at the “upward reflux” that can irritate the throat and sometimes worsen symptoms like cough or asthma. It aims to understand the mechanisms that prevent or allow throat reflux, which may lead to better ways to manage symptoms.

Milwaukee, Wisconsin
NCT04255693Recruiting
Real-life reflux study of diet and behavior changes

This study looks at how following specific diet and behavior changes affects symptoms of acid reflux (heartburn/regurgitation) in everyday life. It may help you understand what lifestyle steps improve reflux and how symptoms change over time.

Moscow
NCT06106100Not yet recruiting
Testing a new procedure for long-term heartburn

This study tests a new procedure called anti-reflux mucosal ablation to see if it helps people with long-lasting heartburn and acid reflux. It might be an option if medications haven't fully controlled your symptoms.

Hear when a new Systemic Sclerosis (SSc) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.